Target
Tyrosine-protein phosphatase non-receptor type 11
Ligand
BDBM503409
Substrate
n/a
Meas. Tech.
Biochemical Assay
IC50
66.0±n/a nM
Citation
 Jorand-LeBrun, CBoivin, RMochalkin, IJohnson, TLinde, NMusch, DKumar, D Carboxamide-pyrimidine derivatives as SHP2 antagonists US Patent  US11033547 Publication Date 6/15/2021 
Target
Name:
Tyrosine-protein phosphatase non-receptor type 11
Synonyms:
PTN11_HUMAN | PTP-1D | PTP-2C | PTP2C | PTPN11 | Protein Tyrosine Phosphatase PPN11/Shp2 | Protein tyrosine phosphatase (PTP) Shp2 | Protein-Tyrosine Phosphatase SHP-2 | Protein-tyrosine phosphatase 2C | SH-PTP3 | SHP2 | SHPTP2 | Src homology phosphatase 2 (SHP-2) | Tyrosine-protein phosphatase non-receptor type 11 | Tyrosine-protein phosphatase non-receptor type 11 (PTPN11) | Tyrosine-protein phosphatase non-receptor type 11 (SHP-2) | Tyrosine-protein phosphatase non-receptor type 11 (SHP2)
Type:
Protein phosphatase
Mol. Mass.:
68443.59
Organism:
Homo sapiens (Human)
Description:
Q06124
Residue:
597
Sequence:
MTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQALLQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETLQRRIEEEQKSKRKGHEYTNIKYSLADQTSGDQSPLPPCTPTPPCAEMREDSARVYENVGLMQQQKSFR
  
Inhibitor
Name:
BDBM503409
Synonyms:
6-Amino-2-[(4-amino-cyclohexyl)- methyl-amino]-5-(2,3-dichloro- phenyl)-pyrimidine-4-carboxylic acid amide | US11033547, Compound 112 | US11696916, Compound 112
Type:
Small organic molecule
Emp. Form.:
C18H22Cl2N6O
Mol. Mass.:
409.313
SMILES:
CN([C@H]1CC[C@H](N)CC1)c1nc(N)c(-c2cccc(Cl)c2Cl)c(n1)C(N)=O |r,wU:2.1,wD:5.5,(1.19,-3.36,;1.59,-1.87,;3.13,-1.87,;3.9,-.53,;5.44,-.53,;6.21,-1.87,;7.75,-1.87,;5.44,-3.2,;3.9,-3.2,;.25,-1.1,;.25,.44,;-1.08,1.21,;-1.08,2.75,;-2.41,.44,;-3.75,1.21,;-3.75,2.75,;-5.08,3.52,;-6.41,2.75,;-6.41,1.21,;-7.75,.44,;-5.08,.44,;-5.08,-1.1,;-2.41,-1.1,;-1.08,-1.87,;-3.5,-2.19,;-2.73,-3.52,;-5.04,-2.19,)|
Structure:
Search PDB for entries with ligand similarity: